News
6d
TipRanks on MSNICU Medical CEO buys $2.47M in common stock
In a regulatory filing, ICU Medical (ICUI) disclosed that its CEO Vivek Jain bought 21.9K shares of common stock on August 14th in a total ...
5d
TipRanks on MSNPiper Sandler bullish on ICU Medical, initiates with an Overweight
As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...
Town Ball coach recovering in ICU after medical emergency at state tournament originally appeared on Bring Me The News. A ...
ICU Medical beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $589.1 million, up 6.5% year on year. It was a mixed quarter for the company, with an impressive beat of ...
ICU Medical’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $186.40 (compared to the current share price of $134.32).
ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical. Operating synergies should provide a path to ICUI trading at 3.35x-3.5x sales in FY'24.
ICU Medical shares do look undervalued, but valuation of slow-growing small-cap medical device companies is tricky, and I'd prefer to see more evidence of stabilization and reacceleration.
ICU Medical now looks to have a multiyear road to get that new business unit up to speed. In the second quarter of 2022, management cut its full-year adjusted EPS and EBITDA guidance range by ...
In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.
View ICU Medical, Inc. ICUI stock quote prices, financial information, real-time forecasts, and company news from CNN.
What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...
ICU Medical Inc. ICUI 0.55% agreed to buy Pfizer Inc.’s infusion-systems business in a $1 billion cash-and-stock deal, giving the California medical-device maker a larger footprint in the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results